{"doi":"10.3389/fimmu.2024.1329805","title":"Gonadal androgens are associated with decreased type I interferon production by plasmacytoid dendritic cells and increased IgG titres to BNT162b2 following co-vaccination with live attenuated influenza vaccine in adolescents","abstract":"mRNA vaccine technologies introduced following the SARS-CoV-2 pandemic have highlighted the need to better understand the interaction of adjuvants and the early innate immune response. Type I interferon (IFN-I) is an integral part of this early innate response that primes several components of the adaptive immune response. Women are widely reported to respond better than men to tri- and quadrivalent influenza vaccines. Plasmacytoid dendritic cells (pDCs) are the primary cell type responsible for IFN-I production, and female pDCs produce more IFN-I than male pDCs since the upstream pattern recognition receptor Toll-like receptor 7 (TLR7) is encoded by X chromosome and is biallelically expressed by up to 30% of female immune cells. Additionally, the TLR7 promoter contains several putative androgen response elements, and androgens have been reported to suppress pDC IFN-I in vitro . Unexpectedly, therefore, we recently observed that male adolescents mount stronger antibody responses to the Pfizer BNT162b2 mRNA vaccine than female adolescents after controlling for natural SARS-CoV-2 infection. We here examined pDC behaviour in this same cohort to determine the impact of IFN-I on anti-spike and anti-receptor-binding domain IgG titres to BNT162b2. Through flow cytometry and least absolute shrinkage and selection operator (LASSO) modelling, we determined that serum-free testosterone was associated with reduced pDC IFN-I, but contrary to the well-described immunosuppressive role for androgens, the most bioactive androgen dihydrotestosterone was associated with increased IgG titres to BNT162b2. Also unexpectedly, we observed that co-vaccination with live attenuated influenza vaccine boosted the magnitude of IgG responses to BNT162b2. Together, these data support a model where systemic IFN-I increases vaccine-mediated immune responses, yet for vaccines with intracellular stages, modulation of the local IFN-I response may alter antigen longevity and consequently improve vaccine-driven immunity.","journal":"Frontiers in Immunology","year":2024,"id":467406,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":3,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9555,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2024-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":624085,"name":"Cecilia Jay","orcid":"0000-0003-2387-9225","position":1,"is_corresponding":false},{"id":464783,"name":"Emily Adland","orcid":null,"position":2,"is_corresponding":false},{"id":624967,"name":"Anna Csala","orcid":null,"position":3,"is_corresponding":false},{"id":555615,"name":"Nicholas Lim","orcid":"0000-0001-9261-7726","position":4,"is_corresponding":false},{"id":1300146,"name":"Stella M. Ebbrecht","orcid":null,"position":5,"is_corresponding":false},{"id":239597,"name":"Lorna C Gilligan","orcid":"0000-0002-0708-2999","position":6,"is_corresponding":false},{"id":239587,"name":"Angela E. Taylor","orcid":"0000-0002-5835-5643","position":7,"is_corresponding":false},{"id":1300147,"name":"Sherley Sherafin George","orcid":null,"position":8,"is_corresponding":false},{"id":1033999,"name":"Stephanie Longet","orcid":null,"position":9,"is_corresponding":false},{"id":1299787,"name":"Lucy C. Jones","orcid":"0000-0002-3872-4376","position":10,"is_corresponding":false},{"id":551307,"name":"Ellie Barnes","orcid":null,"position":11,"is_corresponding":false},{"id":106108,"name":"John Frater","orcid":"0000-0001-7163-7277","position":12,"is_corresponding":false},{"id":106117,"name":"Paul Klenerman","orcid":"0000-0003-4307-9161","position":13,"is_corresponding":false},{"id":1300148,"name":"Susie Dunachie","orcid":null,"position":14,"is_corresponding":false},{"id":1034000,"name":"Miles Carrol","orcid":null,"position":15,"is_corresponding":false},{"id":1035900,"name":"James Hawley","orcid":"0000-0002-9953-5544","position":16,"is_corresponding":false},{"id":239621,"name":"Wiebke Arlt","orcid":"0000-0001-5106-9719","position":17,"is_corresponding":false},{"id":463974,"name":"Andreas Groll","orcid":"0000-0001-6787-9118","position":18,"is_corresponding":false},{"id":106110,"name":"Philip Goulder","orcid":"0000-0002-9842-4674","position":19,"is_corresponding":false},{"id":555620,"name":"Oliver Sampson","orcid":"0000-0001-8727-0588","position":0,"is_corresponding":true}],"reference_count":66,"raw_metadata":null,"created_at":"2026-07-19T02:05:10.907983Z","pmid":"38481993","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}